will ensure that the UK has the best chance to protect those at risk-if the
pharmaceutical companies, the UK has secured early access to 90 million
COVID-19 vaccine doses.
of a vaccine being developed by BioNTech and Pfizer, the first agreement that
the two firms signed with any government. This vaccine reached trials in Phase
agreement for 60 million doses of a vaccine being developed by Valneva, with an
option to get an additional 40 million doses if this vaccine is proven to be
safe, effective and appropriate. Valneva, which has a factory in Livingston,
Scotland, is developing an inactivated virus vaccine and is expected to
contribute to clinical trial costs by the government.
expand the Scottish facility to allow up to 100 million doses to be produced
for the UK and around the world.
and gives the United Kingdom a possible one million doses of COVID-19
neutralizing antibodies that could be used to protect those who cannot be
vaccinated, such as those who are immune-compromised.
England, Scotland, Wales, and Northern Ireland would have sufficient doses to vaccinate
priority groups such as health and social care workers, and those at increased
risk of serious coronavirus complications or death.
the agreements “would ensure the UK has the best possible opportunity to
achieve a vaccine that will protect those at the highest risk.”
Secretary Gavin Williamson, told Sky News that the vaccine is the “best
and safest route out of this crisis.”
“It’s true that the government is investing and placing orders on these
vaccines, so we have a number of options.
that is better positioned to be able to deliver a wide variety of vaccines that
will secure this nation for the future as we recover from this pandemic.”
government has secured access to are:
- A vaccine by Oxford University and
AstraZeneca, which was the first to start Phase 3 trials in May. AstraZeneca
will produce 100 million doses for the UK
- An mRNA vaccine by Imperial College
London, which started human trials in June
chairman said: “The fact that we have so many successful candidates
already shows the incredible speed we are working at.
complacent or too confident. The truth remains that we can never get a vaccine,
even if we have one, we must be prepared not to be a vaccine that stops the
virus from spreading, but instead one that decreases symptoms.
website where people can register to engage in future studies of the vaccines.
signed up by October to enable large-scale studies across the UK to take place.
thousands of volunteers, will help researchers understand each vaccine ‘s
efficacy better, speeding up attempts to figure out what the secret to
preventing the pandemic might be.